Stellaromics was founded in 2022 by a team of world renowned scientists on a mission to move biomedical research forward faster. The Plexa suite of products was developed to extend their progress by empowering others to innovate alongside them. With Plexa, any researcher or clinician can create fully annotated cellular maps for clearer understanding of disease progression and response to therapy.